Equity Capital Markets

Company · CIK 1745999

Beam Therapeutics Inc.

CIK1745999 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedBEAM (Nasdaq)
First annual or quarterly report2020-03-30

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-277427
ShelfEffective
2024-02-282025-03-103
333-254946
ShelfEffective
2021-04-012023-05-104
333-256962
ShelfEffective
2021-06-102021-06-101
333-249093
Registered companyFinal prospectus
2020-09-282020-10-013
333-233985
IPOFinal prospectus
2019-09-272020-02-077

Filings

20
FiledFilingRegistrationAccession
2025-03-10424B5Shelf takedown 333-2774270001193125-25-051106
2025-03-10424B5Shelf takedown 333-2774270001193125-25-050343
2024-02-28S-3ASRShelf registered 333-2774270001193125-24-048201
2023-05-10424B5Shelf takedown 333-2549460001193125-23-140856
2021-07-07424B5Shelf takedown 333-2549460001193125-21-209882
2021-06-10S-3ASRShelf registered 333-2569620001193125-21-187286
2021-04-01424B5Shelf takedown 333-2549460001193125-21-103299
2021-04-01S-3ASRShelf registered 333-2549460001193125-21-103074
2020-10-01424B4Final prospectus 333-2490930001193125-20-261322
2020-09-30EFFECTDeclared effective 333-2490939999999995-20-002643
2020-09-28S-1Registration filed 333-2490930001193125-20-256298
2020-09-18DRSDraft made public 377-035620000950123-20-009821
2020-02-07424B4Final prospectus 333-2339850001193125-20-026941
2020-02-05EFFECTDeclared effective 333-2339859999999995-20-000252
2020-02-05S-1/AAmendment 333-2339850001193125-20-024712
2020-01-31S-1/AAmendment 333-2339850001193125-20-019902
2020-01-27S-1/AAmendment 333-2339850001193125-20-014727
2020-01-17S-1/AAmendment 333-2339850001193125-20-010041
2019-09-27S-1Registration filed 333-2339850001193125-19-257401
2019-07-29DRSDraft made public 377-027570000950123-19-006679

All filings of this company · CSV